£22 million is available for centres of excellence that will provide expert data services meeting the needs of industry, academic and NHS researchers and innovators. The programme is led by Health Data Research UK on behalf of UKRI as part of the Industrial Strategy Challenge Fund.
MRC is pleased to announce it will be launching a fourth call to fund research grants to improve adolescent health in LMICs.
DPFS is an ongoing scheme, with outline deadlines every 4 months.
Further details of open and future DPFS deadlines can be found on the submission deadlines page for the scheme.
The DPFS scheme is a key part of our Translational Research Strategy and supports the translation of fundamental discoveries toward benefits to human health. It funds the pre-clinical development and early clinical testing of novel therapeutics, devices and diagnostics, including “repurposing” of existing therapies.
The Canadian agencies and UKRI are pleased to announce their intention to launch the Canada-UK Artificial Intelligence Initiative. Up to £8 million (CAN $14 million) is available, enough to fund 10 projects between the UK and Canada.
The Medical Research Council (MRC), the UK Economic and Social Research Council (ESRC) and the Canadian Institutes of Health Research (CIHR) are pleased to invite proposals to the UK-Canada Diabetes Partnership Initiative.
The Japan Agency for Medical Research and Development (AMED) and the UK Medical Research Council (UKRI MRC) are pleased to launch a call for proposals for UK-Japan collaborative research into infectious diseases. This jointly funded initiative is aimed at fostering collaborative links between researchers in the UK and Japan.
This joint BBSRC, EPSRC and MRC 2019 Tools and Resources Development Fund (TRDF) call aims to pump prime the next generation of cutting-edge enabling research technologies with the potential for transformative impact in life sciences research.
£4 million is available for existing MRC holders of CDAs and CSFs. The awards will provide those fellows who have not yet achieved outputs suitable to secure follow-on funding via other routes, with short term support to facilitate their transition to research leadership.
The Network of Centres of Excellence in Neurodegeneration (CoEN) is an international initiative involving research funders in Canada, France, Flanders, Germany, Italy, Republic of Ireland, Slovak Republic, Spain and the UK.